Diabetes Treatment Concerns for Individuals with I/DD
Diabetes is one of the most common chronic conditions in adults with I/DD and can result in serious complications if not managed appropriately. In this session, we’ll discuss the top diabetes concerns among this population and how to best manage the disease for optimal outcomes and quality of life.
We’ll focus on treatment options and the unique factors that may impact therapy decisions such as common comorbidities, concerns around metabolic symptoms and compliance/adherence, and medication administration challenges and the importance of support for DSPs. The program will conclude with tips for leveraging your consultant pharmacist to improve individuals’ health, safety, and care.
Tuesday, May 14, 2024
1:00pm ET
Presented by:
Dr. Elizabeth Shauen Howard, VP of Clinical Services and Innovation, BrightSpring Health Services
Matthew Palmer, Manager of Clinical Operations, PharMerica
Steve Austin, Consultant Pharmacist, PharMerica
Learning Objectives:
- Learn the most common diabetes therapies for individuals with I/DD
- Understand unique factors that can impact diabetes treatment in this population
- Identify best practices for medication administration
CE STATEMENT
This program has been approved for nursing Continuing Education for 1 total participant hour, as well as by NAB/NCERS for nursing home administrators, approval #20250513-1-A101797-DL. Audience members MUST be in live attendance for at least 50 minutes to receive 1 contact hour.